scholarly journals IDH1 and IDH2 mutations in lung adenocarcinomas: Evidences of subclonal evolution

2020 ◽  
Vol 9 (12) ◽  
pp. 4386-4394
Author(s):  
Erika F. Rodriguez ◽  
Federico De Marchi ◽  
Parvez M. Lokhandwala ◽  
Deborah Belchis ◽  
Rena Xian ◽  
...  
Keyword(s):  
Idh1 And Idh2 Mutations ◽  
Lung Adenocarcinomas

The tyrosine kinase TEK is differentially expressed in non-small cell lung adenocarcinomas.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
United States ◽  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Microarray Data ◽  
The United States ◽  
Small Cell ◽  
Small Cell Lung ◽  
Significant Differential Expression ◽  
Lung Cancers ◽  
Lung Adenocarcinomas

Non-small cell lung adenocarcinoma (NSCLC) is a leading cause of death in the United States and worldwide (1, 2). We mined published microarray data (3, 4, 5) to discover genes associated with NSCLC. We identified significant differential expression of the tyrosine kinase TEK in tumors from patients with NSCLC. TEK may be of relevance to the initiation, progression or maintenance of non-small cell lung cancers.

Sign in / Sign up

Export Citation Format

Share Document